Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Insights into the structure activity relationship of nitrogen-containing heterocyclics for the development of antidepressant compounds: An updated review
Karanvir Singh, Rohit Pal, Shah Alam Khan, et al.
Journal of Molecular Structure (2021) Vol. 1237, pp. 130369-130369
Closed Access | Times Cited: 82

Showing 1-25 of 82 citing articles:

Synthesis and pharmacological activities of azo dye derivatives incorporating heterocyclic scaffolds: a review
Kibrom Mezgebe, Endale Mulugeta
RSC Advances (2022) Vol. 12, Iss. 40, pp. 25932-25946
Open Access | Times Cited: 78
Pyridine Scaffolds, Phenols and Derivatives of Azo Moiety: Current Therapeutic Perspectives
Tehreem Tahir, Muhammad Ashfaq, Muhammad Saleem, et al.
Molecules (2021) Vol. 26, Iss. 16, pp. 4872-4872
Open Access | Times Cited: 60
Thiazole derivatives in medicinal chemistry: Recent advancements in synthetic strategies, structure activity relationship and pharmacological outcomes
Atamjit Singh, Danish Malhotra, Karanvir Singh, et al.
Journal of Molecular Structure (2022) Vol. 1266, pp. 133479-133479
Closed Access | Times Cited: 55
Designing strategies, structural activity relationship and biological activity of recently developed nitrogen containing heterocyclic compounds as epidermal growth factor receptor tyrosinase inhibitors
Rohit Pal, Ghanshyam Teli, Gurubasavaraja Swamy Purawarga Matada, et al.
Journal of Molecular Structure (2023) Vol. 1291, pp. 136021-136021
Closed Access | Times Cited: 36
Poly (ADP-ribose) polymerase (PARP) inhibitors as anticancer agents: An outlook on clinical progress, synthetic strategies, biological activity, and structure-activity relationship
Pronoy Kanti Das, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, et al.
European Journal of Medicinal Chemistry (2024) Vol. 274, pp. 116535-116535
Closed Access | Times Cited: 12
Benzothiazole a privileged scaffold for Cutting-Edges anticancer agents: Exploring drug design, structure-activity relationship, and docking studies
I. Aayishamma, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116831-116831
Closed Access | Times Cited: 8
Synthesis of new fluorinated sulfonates and their Schiff bases as anti-Alzheimer drug candidates: An in vitro-in silico study
Reşit Çakmak, Eyüp Başaran, Selami Ercan, et al.
Journal of Molecular Structure (2025), pp. 141474-141474
Closed Access | Times Cited: 1
Therapeutic Role of Heterocyclic Compounds in Neurodegenerative Diseases: Insights from Alzheimer’s and Parkinson’s Diseases
Nidhi Puranik, Minseok Song
Neurology International (2025) Vol. 17, Iss. 2, pp. 26-26
Open Access | Times Cited: 1
A synergistic investigation of azo-thiazole derivatives incorporating thiazole moieties: a comprehensive exploration of their synthesis, characterization, computational insights, solvatochromism, and multimodal biological activity assessment
Dara Muhammed Aziz, Sangar Ali Hassan, A. Amin, et al.
RSC Advances (2023) Vol. 13, Iss. 49, pp. 34534-34555
Open Access | Times Cited: 22
Synthetic product-based approach toward potential antileishmanial drug development
Rohit Pal, Ghanshyam Teli, Md Jawaid Akhtar, et al.
European Journal of Medicinal Chemistry (2023) Vol. 263, pp. 115927-115927
Closed Access | Times Cited: 18
Nitrogen‐Containing Heterocyclic Scaffolds as EGFR Inhibitors: Design Approaches, Molecular Docking, and Structure‐Activity Relationships
Rohit Pal, Ghanshyam Teli, Gurubasavaraja Swamy Purawarga Matada, et al.
ChemistrySelect (2023) Vol. 8, Iss. 26
Closed Access | Times Cited: 17
Exploring the impact of trifluoromethyl (–CF3) functional group on the anti-cancer activity of isoxazole-based molecules: design, synthesis, biological evaluation and molecular docking analysis
Paramita Pattanayak, Sripathi Nikhitha, Debojyoti Halder, et al.
RSC Advances (2024) Vol. 14, Iss. 27, pp. 18856-18870
Open Access | Times Cited: 7
Recent Advances of Green Catalytic System I2/DMSO in C–C and C–Heteroatom Bonds Formation
Jiaqi Wang, Zhenyu Zuo, Wei He
Catalysts (2022) Vol. 12, Iss. 8, pp. 821-821
Open Access | Times Cited: 26
Regioselective Synthesis of N2-Aryl 1,2,3-Triazoles via Electro-oxidative Coupling of Enamines and Aryldiazonium Salts
Mrinmay Baidya, Samrat Mallick, Suman De Sarkar
Organic Letters (2022) Vol. 24, Iss. 6, pp. 1274-1279
Closed Access | Times Cited: 24
Pathogenesis of Alzheimer’s Disease and Diversity of 1,2,3-Triazole Scaffold in Drug Development: Design Strategies, Structural Insights, and Therapeutic Potential
Atamjit Singh, Karanvir Singh, Jashandeep Kaur, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 18, pp. 3291-3317
Closed Access | Times Cited: 16
The application of hydrazones and hydrazide-hydrazones in the synthesis of bioactive azetidin-2-one derivatives: A mini review
Łukasz Popiołek
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114853-114853
Open Access | Times Cited: 15
Recent advances in antifungal drug development targeting lanosterol 14α‐demethylase (CYP51): A comprehensive review with structural and molecular insights
Atamjit Singh, Karanvir Singh, Aman Sharma, et al.
Chemical Biology & Drug Design (2023) Vol. 102, Iss. 3, pp. 606-639
Closed Access | Times Cited: 15
Triazolothiadiazoles and triazolothiadiazines as potent α-glucosidase inhibitors: Mechanistic insights from kinetics studies, molecular docking and dynamics simulations
Saeed Ullah, Muhammad Waqas, Sobia Ahsan Halim, et al.
International Journal of Biological Macromolecules (2023) Vol. 250, pp. 126227-126227
Closed Access | Times Cited: 15
Synthesis, computational and antimicrobial study of 2-(2-Hydrazinyl)thiazole derivatives
Rahul A. Shinde, Vishnu A. Adole, Bapu S. Jagdale
Journal of Molecular Structure (2023) Vol. 1300, pp. 137096-137096
Closed Access | Times Cited: 14
Recent drug design strategies and identification of key heterocyclic scaffolds for promising anticancer targets
Alia Mushtaq, Peng Wu, Muhammad Moazzam Naseer
Pharmacology & Therapeutics (2023) Vol. 254, pp. 108579-108579
Closed Access | Times Cited: 13
Pyrazole, Pyrazoline, and Fused Pyrazole Derivatives: New Horizons in EGFR‐Targeted Anticancer Agents
Ketan R Hosamani, K. Hemalatha, Rohit Pal, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 11
Closed Access | Times Cited: 5
Design, synthesis of 1,2,4-triazine derivatives as antidepressant and antioxidant agents: In vitro, in vivo and in silico studies
Rohit Pal, Bhupinder Kumar, Guruubasavaraja Swamy P M, et al.
Bioorganic Chemistry (2022) Vol. 131, pp. 106284-106284
Closed Access | Times Cited: 19
Recent green chemistry approaches for pyrimidine derivatives as a potential anti-cancer agent: An overview (2013–2023)
Kumari Kajal, Ruchi Shakya, Mohd Rashid, et al.
Sustainable Chemistry and Pharmacy (2023) Vol. 37, pp. 101374-101374
Closed Access | Times Cited: 12
Pyrazoline Derivatives as Promising MAO-A Targeting Antidepressants: An Update
Diksha Choudhary, Rajwinder Kaur, Thakur Gurjeet Singh, et al.
Current Topics in Medicinal Chemistry (2024) Vol. 24, Iss. 5, pp. 401-415
Closed Access | Times Cited: 4
Synthesis, Characterization, and Application of pH-Sensitive Monoazo Heterocyclic Disperse Dyes: A Study of Solvatochromism, DFT Analysis, and Biological Activity
Muhammad Salman, Abdul Jabbar, Salma Farooq, et al.
Fibers and Polymers (2025)
Closed Access
Page 1 - Next Page

Scroll to top